Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VINS Polyvalent Antivenom Dose Comparison for Neurotoxic Snake Bite
NCT01284855Phase 2Completed
- Start
- Apr 2011
- Primary completion
- Oct 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of VINS Polyvalent Antivenom in snakebite envenoming. Started Apr 2011; status: completed.
02
Drugs
VINS Polyvalent Antivenom
03
Conditions
snakebite envenoming
Beyond the preview
Go deeper on NCT01284855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01284855.